Alan MacKay

Bio

Joined 3i in 1987 and was appointed to the Board of 3i plc in 1994. Was 3i Investments plc development director for Europe, then managing director of 3i Nordic plc leading the acquisition and integration of listed industrial holding company Atle AB. Was a senior partner in 3i Buyouts immediately prior to becoming founding partner of Quoted Private Equity and subsequently partner of 3i Growth Capital. Public company track record spans fifteen years and includes the minority buy-in of Clyde Blowers plc, the buyout and IPO of Workplace Technologies plc. Global lead partner of 3i Healthcare, which comprises 18 healthcare investors in Asia, Europe and the US. 3i Heralthcare recent (2008) investments include Quintiles, Alpharma API, Ultralase, and Phibro Animal Health. He is chairman of central and eastern Europe specialist investor 3TS Capital Partners. Currently non-executive director of Character Group plc, MDY Healthcare plc, and Phibro Animal Health Corporation, all listed in London, and is a member of the Strategic Advisory Board at SVG. LLB in Law from the University of Glasgow, a Masters Degree in Enterprise Economics from the University of Stirling, and has completed the INSEAD Advanced Management Programme.